ORCSDirexion Daily ORCL Bear 1X ETF
Seeks daily investment results of 100% of the inverse performance of ORCL.
By Direxion Funds · Launched 2025
0.97%
#4,819 of 5,562 · expensive
$6M
#4,954 of 5,562 · small
N/A
7 months
#4,993 of 5,562 · young
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightAsset allocation
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsWorst peak-to-trough loss
Needs 3+ years of history
Needs 3+ years of history
Where to buy
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Seeks daily investment results of 100% of the inverse performance of ORCL.
- Strategy
- Invests primarily in financial instruments, including swaps and options, to provide 1X daily inverse exposure to ORCL. The Fund rebalances daily to maintain this exposure, resulting in high portfolio turnover. It may hold money market funds and short-term debt instruments with high credit quality.
- Inception date
- November 18, 2025
- Fund family
- Direxion Funds
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Inverse ETF — daily tool only
Delivers the inverse of the benchmark's daily return. The compounding path makes multi-day holding unpredictable even when the benchmark's total move goes your way. Legitimate as a one-day hedge; dangerous as a view.
Source: Cheng & Madhavan (2009)
Why we flagged this: strategy=inverse + inverse_name_or_strategy
Single-stock wrapper — fees without diversification
This fund wraps exposure to a single company, usually with an option overlay. You pay fund-level fees (typically 0.50–1.00% depending on the issuer) plus the wrapper's option-overlay mechanics for exposure you could get more cheaply by holding the underlying stock directly. The income is generated by capping upside.
Source: Israelov & Nielsen, 'Covered Calls Uncovered' (Financial Analysts Journal 2015)
Why we flagged this: strategy=inverse + single_stock_wrapper
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed ORCS. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19